In 2024, we launched some of our most innovative mixed reality, AI and Metaverse products yet. Now, our CTO Andrew Bosworth explains why we plan to accelerate in 2025.
CellarisBio breaks ground with an announcement of "Challenging Target Award" to foster innovation in the space of challenging therapeutic targets. The award is designed to de-risk & accelerate ...
After two quarters of declines, global shipments of AR/VR headsets finally returned to growth as volumes rose 12.8% during the ... The exclusive group represent the best and brightest across all ...